Latest Breaking News On - தத்வா சிந்தன் - Page 1 : vimarsana.com

At the issue price, the Tatva Chintan commanded a PE of 41.62 times and a market-cap of Rs 2,400 crore compared with listed peers Aarti Industries 63 times and Navin Fluorine International at 61.4 times. Astha Jain of Hem Securities advised long-term investors to pare at least 50 per cent of their holdings. Investors, who were seeking listing gains only, should book 100 per cent profits on Day 1 itself, she said. The Rs 500 crore IPO, which was sold from July 16 to 20, saw strong demand. Overall, the issue was subscribed over 180 times, with the quota reserved for qualified institutional buyers (QIBs) 185.23 times while the one reserved for non-institutional investors (NIIs) 512.22 times. The retail quota was subscribed 35.35 times.

Tatva chintan pharmaAarti industriesTatva chintanAstha jainNavin fluorine internationalTatva chintan pharma chemClean scienceHem securitiesChintan pharma chemதத்வா சிந்தன் பார்மாஆர்த்தி தொழில்கள்தத்வா சிந்தன்ஆஸ்தா ஜெயின்நவீன் ஃப்ளோரின் சர்வதேசதத்வா சிந்தன் பார்மா செம்சுத்தமான அறிவியல்